Cipla has received final approval for its abbreviated new drug application for Efavirenz tablets 600mg from the USFDA. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults
Infosys expands footprint in france by establishing state-of-the-art digital center of excellence in Marseille
Brigade Enterprises board meeting on June 22 to consider proposal for fund raising by issue of non-convertible debentures
For more information Whatsapp@ +91-9755855566 or visit@ http://www.saiproficient.com/
Infosys expands footprint in france by establishing state-of-the-art digital center of excellence in Marseille
Brigade Enterprises board meeting on June 22 to consider proposal for fund raising by issue of non-convertible debentures
For more information Whatsapp@ +91-9755855566 or visit@ http://www.saiproficient.com/
No comments:
Post a Comment